Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region

Immunogenetics

Volumn 57, Issue 10, 2005, Pages 795-799

  Schooten, Erik ^a   Klous, Petra ^a   Van Den Elsen, Peter J ^a,b   Holling, Tjadine M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

DNA methylation; Epigenetic modification; Mouse; T cell

Indexed keywords

CLASS II TRANSACTIVATOR PROMOTER III; DEOXYCYTIDINE; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; ISOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURFACE; CORRELATION ANALYSIS; DNA METHYLATION; EPIGENETICS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL LINE; DNA METHYLATION; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; MICE; NUCLEAR PROTEINS; T-LYMPHOCYTES; TRANS-ACTIVATORS;

ANIMALIA;

EID: 27744601009     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-005-0051-8     Document Type: Article

References (13)

1. Chang CH, Hong SC, Hughes CC, Janeway CA Jr, Flavell RA (1995) CIITA activates the expression of MHC class II genes in mouse T cells. Int Immunol 7:1515-1518
2. Holling TM, van der Stoep N, Quinten E, van den Elsen PJ (2002) Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III. J Immunol 168:763-770
3. Holling TM, Schooten E, Langerak AW, van den Elsen PJ (2004) Regulation of MHC class II expression in human T-cell malignancies. Blood 103:1438-1444
4. Keshet I, Lieman-Hurwitz J, Cedar H (1986) DNA methylation affects the formation of active chromatin. Cell 44:535-543
5. Ko HS, Fu SM, Winchester RJ, Yu DT, Kunkel HG (1979) Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med 150:246-255
6. Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B (1997) Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 16:2851-2860
7. Muhlethaler-Mottet A, Di Berardino W, Otten LA, Mach B (1998) Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity 8:157-166
8. Otten LA, Tacchini-Cottier F, Lohoff M, Annunziato F, Cosmi L, Scarpellino L, Louis J, Steimle V, Reith W, Acha-Orbea H (2003) Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes. J Immunol 170:1150-1157
9. Piskurich JF, Wang Y, Linhoff MW, White LC, Ting JP (1998) Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene. J Immunol 160:233-240
10. van den Elsen PJ, van der Stoep N, Viëtor HE, Wilson E, van Zutphen M, Gobin SJP (2000) Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblasts cells and is caused by methylation of the IFNg inducible promoter (PIV) of CIITA. Hum Immunol 61:850-862
11. van der Stoep N, Quinten E, van den Elsen PJ (2002) Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5′-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-premoter III transcriptional activation in B lymphocytes. J Immunol 169: 5061-5071
12. Waldburger JM, Rossi S, Hollander GA, Rodewald HR, Reith W, Acha-Orbea H (2003) Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells. Blood 101:3550-3559
13. Wong AW, Ghosh N, McKinnon KP, Reed W, Piskurich JF, Wright KL, Ting JP (2002) Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes and cell line. J Immunol 169:3112-3119